» Articles » PMID: 37355586

Local Anesthetics Systemic Toxicity in Children: Analysis of the French Pharmacovigilance Database

Overview
Journal BMC Pediatr
Publisher Biomed Central
Specialty Pediatrics
Date 2023 Jun 24
PMID 37355586
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To characterize clinical profile of pediatric local anesthetic (LA) systemic toxicity (LAST) and to identify determinants of life-threatening outcomes.

Methods: Spontaneous reports notified to the French Pharmacovigilance Network were retrieved and followed by a case-by-case review, according to the following criteria: LA as suspected drug, age < 18 years, adverse drug reactions related to nervous system, cardiac, respiratory, psychiatric or general disorders. Multivariate logistic regression analysis was performed to identify factors leading to life-threatening reaction (i.e. continuous seizures or cardiorespiratory arrest).

Results: Among 512 cases retrieved, 64 LAST cases were included (neonates 11%, infants 30%, children 36%, adolescents 23%) mainly involving lidocaine (47%), lidocaine + prilocaine (22%) and ropivacaine (14%). Toxicity profiles were neurological (58%), cardiac (11%) or mixed (20%) and 7 patients (11%) developed methemoglobinemia. LAST was life-threatening for 23 patients (36%) and 2 patients died. Doses were above recommendations in 26 patients (41%) and were not different between life-threatening and non-life-threatening cases. The context of use (general and orthopedic surgery, p = 0.006) and the type of LA agent (lidocaine, p = 0.016) were independently associated with a life-threatening outcome.

Conclusion: In this national retrospective analysis, LAST in children appear to be a rare event. Neurological and cardiac signs were the most frequently reported reactions. LAST in children can be life-threatening, even at therapeutic doses. Although a fatal outcome may anecdotally occur, the vast majority of patients recovered after appropriate medical care.

Citing Articles

Local Lidocaine-Prilocaine for Immunisation in Infants.

Pop C, Coblisan P, Sas V, Druga C, Chereches-Panta P Vaccines (Basel). 2025; 12(12.

PMID: 39771991 PMC: 11680039. DOI: 10.3390/vaccines12121329.


Ultrasound guided pediatric caudal dose: a two-center randomized controlled trial.

Syal K, Chandel A, Kanwar M BMC Anesthesiol. 2024; 24(1):401.

PMID: 39506646 PMC: 11539251. DOI: 10.1186/s12871-024-02752-x.


A case of a lidocaine intoxication of a 12 week old boy due to a circumcision in a domestic setting - clinical, toxicological and forensic aspects.

Dyballa N, Hartel J, Prangenberg J, Andresen-Streichert H Forensic Sci Med Pathol. 2024; .

PMID: 39088142 DOI: 10.1007/s12024-024-00859-8.

References
1.
Gunter J . Benefit and risks of local anesthetics in infants and children. Paediatr Drugs. 2002; 4(10):649-72. DOI: 10.2165/00128072-200204100-00003. View

2.
Tran A, Koo J . Risk of systemic toxicity with topical lidocaine/prilocaine: a review. J Drugs Dermatol. 2014; 13(9):1118-22. View

3.
Lerman J, Strong H, Ledez K, Swartz J, Rieder M, Burrows F . Effects of age on the serum concentration of alpha 1-acid glycoprotein and the binding of lidocaine in pediatric patients. Clin Pharmacol Ther. 1989; 46(2):219-25. DOI: 10.1038/clpt.1989.129. View

4.
Taylor A, McLeod G . Basic pharmacology of local anaesthetics. BJA Educ. 2021; 20(2):34-41. PMC: 7808030. DOI: 10.1016/j.bjae.2019.10.002. View

5.
Dickerson D, Apfelbaum J . Local anesthetic systemic toxicity. Aesthet Surg J. 2014; 34(7):1111-9. DOI: 10.1177/1090820X14543102. View